Sonoma Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The …

Drug Manufacturers - Specialty & Generic
US, Woodstock [HQ]

News

Theses · Events · Sentiments
End of SNOA's Analysis
CIK: 1367083 CUSIP: 83558L204 ISIN: US83558L2043 LEI: - UEI: -
Secondary Listings
SNOA has no secondary listings inside our databases.